regulatory
confidence high
sentiment negative
materiality 0.60
Applied UV, Inc.: Nasdaq/NYSE listing notice — Applied UV receives Nasdaq delisting notice for Audit Committee non-compliance
Applied UV, Inc.
- Notice dated May 15, 2024: Audit Committee now has only 2 independent directors after Eugene Burleson's resignation.
- Cure period until earlier of next annual meeting or May 7, 2025; if annual meeting before Nov 4, 2024, compliance by Nov 4, 2024.
- Company intends to elect one independent director to fill Audit Committee vacancy.
- Appointed Christopher Kochuba to Audit and Compensation Committees effective May 14, 2024.
- No immediate effect on listing or trading of AUVI or AUVIP on Nasdaq.